Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ADTX

Aditxt, Inc.

Healthcare | Biotechnology
$0.01 -0.00 (-15.50%) as of 2026-07-15 05:52 UTC
Volume1.07B
EPS (TTM)$-1,153.83

Aditxt, Inc. (NASDAQ: ADTX) is a biotechnology company trading at $0.01 (−15.5% today). Figures from SEC EDGAR and market feeds; updated 2026-07-15 05:52 UTC.

52-Week Range
Low $0.01High $53,453.52

What Aditxt, Inc. does

The company was incorporated in Delaware and is headquartered in Mountain View, California, with a mission to transform how health innovations are discovered, developed, and deployed by engaging broad groups of stakeholders. The company's main focus is through its subsidiary Adimune, Inc., which develops immune modulation therapies based on Apoptotic DNA Immunotherapy (ADI), a technology licensed from Loma Linda University.

Summarized from Aditxt, Inc.’s SEC filings · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.
Key facts
Quote
Price$0.01
Change (1D)-0.00 (-15.50%)
Volume1.07B shares
52-week range$0.01 – $53,453.52
Valuation
EPS (TTM)$-1,153.83
Debt/equity0.33
Returns
52-week return+21.1%
Revenue, margins & earnings
FY2021: net loss $46M on revenue $105,034$105,034FY2021FY2022: net loss $28M on revenue $933,715$933,715FY2022FY2023: net loss $33M on revenue $645,176$645,176FY2023FY2024: net loss $40M on revenue $133,985$133,985FY2024FY2025: net loss $43M on revenue $3,195$3,195FY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-06-25
  • 2026-06-25Takeover Time 2026 LLCSELL-3,420,439$68.4K
  • 2026-06-24HRT FINANCIAL LPBUY7,340,178$95.4K
  • 2026-06-24HRT FINANCIAL LPSELL-5,120,480$92.2K
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP16,079$13.4K-50.5%
  • HRT FINANCIAL LP15,904$13.0K+18.2%
  • Virtu Financial LLC16,225$12.0K-21.9%
View QoQ ownership changes →
Company news View all →
No qualifying company news in the archive. Full tape in the platform →
Questions this page answers

What does Aditxt, Inc. do?

The company was incorporated in Delaware and is headquartered in Mountain View, California, with a mission to transform how health innovations are discovered, developed, and deployed by engaging broad groups of stakeholders.

What is ADTX's valuation?

ADTX trades at $0.01, as of 2026-07-15.

When did ADTX last file with the SEC?

Aditxt, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-24. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-15 05:52 UTC. This page is also available as JSON at /api/data?ticker=ADTX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ADTX and 3,500+ tickers.

Create a free account — keep ADTX
For your agent
GET /api/data?ticker=ADTX

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt